Lamivudine and Famciclovir Combination Therapy with or without Addition of Interferon-alpha-2b for HBeAg-positive Chronic Hepatitis B: A Pilot Study

Author： Sangfelt Per   Uhnoo Ingrid   Hollander Anna   Lindh Gudrun   Weiland Ola  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.34, Iss.7, 2002-07, pp. : 505-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 341-349

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of HBeAg-Positive Young Adult Japanese Patients Treated with Corticosteroid Withdrawal Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 339-345

Karger

Access to resources Recommend Favorite

Evolution of Hepatitis C Virus Quasispecies during Ribavirin and Interferon-Alpha-2b Combination Therapy and Interferon-Alpha-2b Monotherapy

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 352-361

Karger

Access to resources Recommend Favorite

Clinical Course of Virologic Breakthrough after Emergence of YMDD Mutations in HBeAg-Positive Chronic Hepatitis B

By  

Intervirology, Vol. 51, Iss. 4, 2008-11 ,pp. : 293-298

Karger

Access to resources Recommend Favorite

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa‐2b in HBeAg‐positive patients

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 9, 2010-09 ,pp. : 1498-1506

John Wiley & Sons Inc

Access to resources Recommend Favorite